1. Home
  2. PVH vs CRNX Comparison

PVH vs CRNX Comparison

Compare PVH & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PVH Corp.

PVH

PVH Corp.

HOLD

Current Price

$66.14

Market Cap

3.2B

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$33.73

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PVH
CRNX
Founded
1881
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.9B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
PVH
CRNX
Price
$66.14
$33.73
Analyst Decision
Buy
Strong Buy
Analyst Count
16
9
Target Price
$89.27
$74.78
AVG Volume (30 Days)
808.9K
1.0M
Earning Date
03-31-2026
05-07-2026
Dividend Yield
0.23%
N/A
EPS Growth
N/A
N/A
EPS
3.72
N/A
Revenue
$8,652,900,000.00
$1,039,000.00
Revenue This Year
$3.66
$722.66
Revenue Next Year
$1.79
$183.79
P/E Ratio
$17.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.28
$24.10
52 Week High
$89.79
$57.99

Technical Indicators

Market Signals
Indicator
PVH
CRNX
Relative Strength Index (RSI) 53.42 29.20
Support Level $60.58 $33.23
Resistance Level $71.32 $37.23
Average True Range (ATR) 2.08 1.62
MACD 0.49 0.13
Stochastic Oscillator 71.50 8.33

Price Performance

Historical Comparison
PVH
CRNX

About PVH PVH Corp.

PVH designs and markets branded apparel in more than 40 countries. Its key fashion categories include men's dress shirts, ties, sportswear, underwear, and jeans. Its two designer brands, Calvin Klein and Tommy Hilfiger, now generate practically all its revenue after its recent disposition of most of its smaller brands. PVH operates e-commerce sites, about 1,400 stores, and about 1,500 shop-in-shops and concessions. The firm also licenses its brands to third parties and distributes its merchandise through department stores and other wholesale accounts. PVH traces its history to 1881 and is based in New York City.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: